IL43335A0 - 2-(2-pyridyl)-omega-phenylalkylamines,their preparation and pharmaceutical compositions containing them - Google Patents

2-(2-pyridyl)-omega-phenylalkylamines,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL43335A0
IL43335A0 IL43335A IL4333573A IL43335A0 IL 43335 A0 IL43335 A0 IL 43335A0 IL 43335 A IL43335 A IL 43335A IL 4333573 A IL4333573 A IL 4333573A IL 43335 A0 IL43335 A0 IL 43335A0
Authority
IL
Israel
Prior art keywords
phenylalkylamines
omega
pyridyl
preparation
pharmaceutical compositions
Prior art date
Application number
IL43335A
Other languages
English (en)
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of IL43335A0 publication Critical patent/IL43335A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57—Nitriles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL43335A 1972-10-02 1973-09-26 2-(2-pyridyl)-omega-phenylalkylamines,their preparation and pharmaceutical compositions containing them IL43335A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00293863A US3819641A (en) 1972-10-02 1972-10-02 2-(2-pyridyl)-omega-phenylalkylamines

Publications (1)

Publication Number Publication Date
IL43335A0 true IL43335A0 (en) 1973-11-28

Family

ID=23130909

Family Applications (1)

Application Number Title Priority Date Filing Date
IL43335A IL43335A0 (en) 1972-10-02 1973-09-26 2-(2-pyridyl)-omega-phenylalkylamines,their preparation and pharmaceutical compositions containing them

Country Status (19)

Country Link
US (1) US3819641A (fr)
JP (1) JPS614832B2 (fr)
AT (1) AT329558B (fr)
AU (1) AU6067373A (fr)
BE (1) BE805529A (fr)
CA (1) CA1018169A (fr)
CH (1) CH583704A5 (fr)
DE (1) DE2349493A1 (fr)
DK (1) DK143981C (fr)
FI (1) FI56966C (fr)
FR (1) FR2201099B1 (fr)
GB (1) GB1440777A (fr)
IE (1) IE40373B1 (fr)
IL (1) IL43335A0 (fr)
NL (1) NL178787C (fr)
NO (1) NO140186C (fr)
PH (1) PH10660A (fr)
SE (1) SE394431B (fr)
ZA (1) ZA737710B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923988A (en) * 1972-10-02 1975-12-02 Robins Co Inc A H 2-(2-pyridyl)-{107 -phenylalkylamines
US4562258A (en) * 1982-02-04 1985-12-31 Findlay John W A 6-[3-Amino-1-(4-tolyl)prop-1E-enyl]pyridine-2-carboxylic acid derivatives having antihistaminic activity
US4584382A (en) * 1983-02-01 1986-04-22 Findlay John W A Pyridyl acrylate compound
US4621094A (en) * 1983-03-10 1986-11-04 Findlay John W A Anti-histaminic pyridyl compounds
JPH0434982Y2 (fr) * 1986-11-21 1992-08-19
US5430044A (en) * 1987-02-06 1995-07-04 Fisons Corporation Arylalkyl-amines and -amides having anticonvulsant and neuroprotective properties
CN108314631A (zh) * 2018-04-19 2018-07-24 中国科学院昆明植物研究所 二芳基乙烯类化合物及其药物组合物和其应用

Also Published As

Publication number Publication date
ATA843073A (de) 1975-08-15
FI56966B (fi) 1980-01-31
NL178787B (nl) 1985-12-16
PH10660A (en) 1977-07-27
US3819641A (en) 1974-06-25
IE40373L (en) 1974-04-02
DE2349493A1 (de) 1974-04-18
JPS614832B2 (fr) 1986-02-13
BE805529A (fr) 1974-02-01
CA1018169A (en) 1977-09-27
AT329558B (de) 1976-05-25
DK143981C (da) 1982-04-26
FI56966C (fi) 1980-05-12
DK143981B (da) 1981-11-09
FR2201099B1 (fr) 1977-01-28
IE40373B1 (en) 1979-05-23
SE394431B (sv) 1977-06-27
FR2201099A1 (fr) 1974-04-26
CH583704A5 (fr) 1977-01-14
NO140186C (no) 1979-07-18
NL7313472A (fr) 1974-04-04
GB1440777A (en) 1976-06-23
JPS49132077A (fr) 1974-12-18
NL178787C (nl) 1986-05-16
NO140186B (no) 1979-04-09
AU6067373A (en) 1975-03-27
ZA737710B (fr) 1974-08-28

Similar Documents

Publication Publication Date Title
IL42430A0 (en) Pyridopyrrolobenzheterocycles,their preparation and pharmaceutical compositions containing them
IL41825A0 (en) Novel pyridine derivatives,their preparation and pharmaceutical compositions containing them
IL43762A (en) 11,11-alkylidene-steroids their preparation and pharmaceutical compositions containing them
IL42102A0 (en) Novel benzoxazole derivatives,their preparation and pharmaceutical compositions containing them
IL43837A0 (en) New aminophenyl-ethanolamines and corresponding oxazolidines,their preparation and pharmaceutical compositions containing them
IL43001A0 (en) Novel 4-biphenylyl-alcohols,their preparation and pharmaceutical compositions containing them
IL41788A0 (en) Isoindoline derivatives,processes for their preparation and pharmaceutical compositions containing them
IL42429A0 (en) 2-alkoxycephalosporins,their preparation and pharmaceutical compositions containing them
IL41220A0 (en) Thioxanthone-2-carboxylic acids and derivatives thereof,their preparation and pharmaceutical compositions containing them
IL49286A0 (en) Novel 1-iodo-1-trans-alkenes,their preparation and pharmaceutical compositions containing them
IL43335A0 (en) 2-(2-pyridyl)-omega-phenylalkylamines,their preparation and pharmaceutical compositions containing them
IL41259A0 (en) Isoindoline derivatives,processes for their preparation and pharmaceutical compositions containing the same
IL43283A0 (en) Indoloquinoline derivatives,their preparation and pharmaceutical compositions containing them
IL41512A0 (en) New oxazoles,their preparation and pharmaceutical compositions containing them
IL41562A0 (en) Novel morphinan derivatives,their manufacture and pharmaceutical compositions containing them
IL42613A0 (en) Amino-imidazo-and amino-pyrazolo-isoquinolines,their preparation and pharmaceutical compositions containing them
IL42790A0 (en) 4a-aryl-trans-decahydroisoquino-lines,their preparation and pharmaceutical compositions containing them
IL40747A0 (en) 1-phenyl-3-hydroxy-3-methyl-triazenes,their preparation and pharmaceutical compositions containing them
ZA733340B (en) New 6alpha-methylprednisolone derivatives,preparation process and pharmaceutical compositions
IL42354A0 (en) Anhydrofuranose derivatives,their manufacture and pharmaceutical compositions containing them
IL41715A0 (en) Diphenylmethane derivatives,their preparation and pharmaceutical compositions containing them
IL42309A0 (en) New heterocyclic derivatives,preparation process and pharmaceutical compositions
IL42435A0 (en) Novel diaminoacridine derivatives,their preparation and pharmaceutical compositions containing them
IL43000A0 (en) Novel biphenylyl-furans,their preparation and pharmaceutical compositions containing them
IL43272A0 (en) 1,4-benzodioxan derivatives,their preparation and pharmaceutical compositions containing them